Marche Polytechnic University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Ancona Italy (1969)

Organization Overview

First Clinical Trial
2000
NCT02048215
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

A.O. Ospedali Riuniti Marche Nord | A.O. Ospedali Riuniti Marche Nord - Presidio S. Salvatore Muraglia, Oncologia | A.O.Universitaria Ospedali Riuniti, Ancona | AOU Ospedali Riuniti di Ancona, Italy | Azienda Ospedaliera Ospedali Riuniti Marche Nord | Azienda Ospedaliera Ospedali Riuniti Marche Nord, Italy | Azienda Ospedaliera Ospedali Riuniti Marche Nord, U.O.C. Oncologia, Ospedale San Salvatore | Azienda Ospedaliero Universitaria OORR Umberto I - Marche | Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona | Clinica di Ematologia A.O.Universitaria Ospedali Riuniti, Ancona | Ospedale di Ancona | Ospedali Riuniti Ancona | Ospedali Riuniti di Ancona | Univeristà Politecnica delle Marche, Ancona, Italy | Università Politecnica delle Marche | Virgilio Paolo Carnielli

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 2)

Carcinoma (Phase 2)

Carcinoma, Renal Cell (Phase 2)

Graft vs Host Disease (Phase 1)

Lung Diseases, Interstitial (Phase 2)

Lung Neoplasms (Phase 2)

Lymphoma (Phase 2)

Lymphoma, B-Cell (Phase 2)

Lymphoma, Non-Hodgkin (Phase 2)

Multiple Myeloma (Phase 3)

Neoplasm Metastasis (Phase 2)

Neoplasms, Plasma Cell (Phase 3)

Obesity (Phase 3)

Pneumonia (Phase 2)

Respiratory Distress Syndrome (Phase 4)

Respiratory Distress Syndrome, Newborn (Phase 4)

Scleroderma, Diffuse (Phase 3)

Scleroderma, Systemic (Phase 3)

Sepsis (Phase 2)

Shock (Phase 2)

Shock, Septic (Phase 2)

Small Cell Lung Carcinoma (Phase 2)

Status Epilepticus (Phase 3)

Stomach Neoplasms (Phase 3)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 22
  • # of Trial APIs: 35